Variables associated with glycemic target goal (HbA1c<7.0% without hypoglycemia) at 12 months
| Standardized β | P value | OR | 95% CI | ||
| Lower | Upper | ||||
| Age (years) | −0.013 | 0.536 | 0.987 | 0.947 | 1.029 |
| Male versus female | 0.339 | 0.528 | 1.404 | 0.490 | 4.025 |
| Initial triple versus conventional therapy | 1.021 | 0.007 | 2.776 | 1.327 | 5.808 |
| DM duration: <24 months vs ≥24 months | 1.662 | <0.001 | 5.272 | 2.253 | 12.335 |
| Family history of DM: yes versus no | 0.264 | 0.482 | 1.302 | 0.624 | 2.716 |
| Hypertension: yes versus no | 0.428 | 0.346 | 1.534 | 0.630 | 3.738 |
| Body mass index (kg/m2) | 0.015 | 0.772 | 1.015 | 0.918 | 1.123 |
| Systolic blood pressure (mm Hg) | −0.009 | 0.484 | 0.991 | 0.966 | 1.016 |
| Fasting plasma glucose (mg/dL) | 0.001 | 0.741 | 1.001 | 0.995 | 1.008 |
| HbA1c (%) | −0.039 | 0.861 | 0.962 | 0.621 | 1.488 |
| C-peptide (ng/mL) | 0.276 | 0.085 | 1.318 | 0.963 | 1.802 |
| Total cholesterol (mg/dL) | −0.005 | 0.266 | 0.995 | 0.986 | 1.004 |
| Triglyceride (mg/dL) | 0.001 | 0.929 | 1.000 | 0.998 | 1.003 |
| ALT (IU/L) | −0.008 | 0.335 | 0.992 | 0.976 | 1.008 |
| Serum creatinine (mg/dL) | 1.366 | 0.274 | 3.920 | 0.338 | 45.409 |
Multivariable logistic regression analysis was performed.
ALT, alanine aminotransferase; DM, diabetes mellitus.